Get started
Author

Neeraj Markandeywar

Institution: Sun Pharma (India)
ORCID: 0009-0009-6300-6665
Observed ORCID: 0009-0009-6300-6665
OpenAlex ID: A5058682949
Effectiveness of Oral Cephalexin-Clavulanic Acid, Cefuroxime, and Amoxicillin-Clavulanic Acid in the Management of Dental Infections: A Real-World, Retrospective, Electronic Medical Record-Based Study in India
2023 · Kalyan Banerjee, Ajay Kakkar, et al. · Drugs - Real World Outcomes · 10
PDF
Exploring the common pathophysiological links between IPF, SSc-ILD and post-COVID fibrosis
2022 · Rajesh Swarnakar, Yogesh Garje, et al. · Lung India · 9
Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India
2025 · Yogesh Garje, Rajiv Saikia, et al. · Drugs - Real World Outcomes · 3
PDF
Sitagliptin as an Add-on Therapy to Other Glucose-lowering Agents in Patients with Type 2 Diabetes Mellitus: A Narrative Review.
2025 · Sanjay Kalra, Awadhesh Kumar Singh, et al. · PubMed · 3
Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
2021 · Venkata Nagarjuna Maturu, Priti Meshram, et al. · Respirology Case Reports · 3
PDF
Professional outcome of medical graduates: a 17 year cross-sectional study from India
2017 · Avinash Pandey, Richa Mishra, et al. · International Journal of Community Medicine and Public Health · 2
PDF
Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study
2026 · Yogesh Garje, Tanish Modi, et al. · Drugs - Real World Outcomes · 1
1150: Fexuprazan, a Novel Potassium-competitive Acid Blocker Vs. Esomeprazole in Indian Patients With Erosive Esophagitis: a Phase 3, Multicentre, Randomized, Active-controlled Study
2025 · Shravan Kumar, Santosh Hajare, et al. · Gastroenterology · 1
Real-world effectiveness of dapagliflozin and sitagliptin fixed-dose combination in indian patients with type 2 diabetes: a retrospective analysis of electronic medical records stratified by BMI
2024 · Rajiv Kovil, Rajesh Deshmane, et al. · Endocrine Abstracts · 1
Nutritional therapy in liver cirrhosis: an update on role of branched chain amino acids
2024 · Shagupta Shaikh, Rakhi Maiwall, et al. · Journal of Clinical and Experimental Hepatology · 1
Physician beliefs and management practices of coexistent Asthma-Allergic Rhinitis: Indian results from multi-country ASPAIR study
2020 · Neeraj Markandeywar, Vaibhav Kubal, et al. · IP Indian Journal of Immunology and Respiratory Medicine · 1
PDF
CONTROL-IHD Study: 24-h BP Control with Metoprolol-Telmisartan FDC in Hypertension and Stable Ischemic Disease
2026 · Kamal Sharma, Gaurav Chhaya, et al. · Advances in Therapy
PDF
Correction: Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based Study
2026 · Yogesh Garje, Tanish Modi, et al. · Drugs - Real World Outcomes
PDF
Safety and Efficacy of Fixed-Dose Pantoprazole and Sustained Release Levosulpiride for Short-Term Management of Gastroesophageal Reflux Disease
2026 · Yogesh Garje, Vijay Kamat, et al. · Gastroenterology Research
PDF
Effectiveness and tolerability of cephalexin and clavulanic acid fixed dose combination, amoxicillin and clavulanic acid fixed dose combination, and azithromycin in patients with pharyngitis in India: a real-world retrospective study from electronic medical records (PHARYSPOR)
2026 · Subramanyam Sarof, Nikita Kariappa Somana, et al. · Frontiers in Medicine
PDF
Perspectives of Indian Gastroenterologists and Hepatologists on Nonalcoholic Fatty Liver Disease Diagnosis and Management: Insights From the Nationwide Web-Based Cross-Sectional DRIVE Survey
2026 · Anil Arora, Yogesh Garje, et al. · Interactive Journal of Medical Research
PDF
A real-world retrospective electronic medical record (EMR)-based study to evaluate effectiveness and tolerability of Ticagrelor in Indian patients with Acute coronary Syndrome (ACS)
2025 · Rajnish Dhediya, Prathap Kumar N, et al. · Indian Heart Journal
Durability of glycemic response with FDC of sitagliptin and metformin in treatment naive T2DM indian patients from a real-world retrospective EMR based study
2025 · Pranav Sheth, Parag Shah, et al. · Endocrine Abstracts
Assessment of atherosclerotic cardiovascular disease (ASCVD) risk using ASCVD risk estimator plus in indian patients with type 2 diabetes - a subgroup analysis from real-world, retrospective study
2025 · Pranav Sheth, Ajit Mullasari, et al. · Endocrine Abstracts
Efficacy and Safety of Metoprolol+telmisartan Fdc in Essential Hypertension: Treatment on Variability Index and Smoothness Index Analyses Assessed by Ambulatory Bp Monitoring
2025 · Prachi Ahire, Kamal Sharma, et al. · Journal of Hypertension
Effectiveness & Tolerability of Metoprolol Er, Telmisartan & Chlorthalidone Fdc in Patients of Essential Hypertension With Stable Cad in India: Real World Retrospetive Study
2025 · Prachi Ahire, M Vijaykaumar, et al. · Journal of Hypertension
Exploring the Role of Sitagliptin in the Management of Type 2 Diabetes Mellitus for the Elderly: A Narrative Review.
2025 · Bipin Sethi, Mathew John, et al. · PubMed
Revisiting the Cardiorenal Safety of Sitagliptin in Type 2 Diabetes Mellitus: A Literature Review.
2025 · Parag Shah, Mangesh Tiwaskar, et al. · PubMed
Beliefs and Practices of Healthcare Practitioners Regarding Management of Malnutrition in Liver Cirrhosis Patients in India (BELIV Survey)
2025 · Neeraj Markandeywar, Rakhi Maiwall, et al. · Journal of Clinical and Experimental Hepatology
Survey to understand current management practices among healthcare professionals for Indian patients with dyslipidemia (Control survey)
2024 · Pranav Sheth, Arindam Pande, et al. · Indian Heart Journal
Works count: 32
Citation count: 35
H-index: 3
I10-index: 1
Year
Topic
Type